One large U.S. study found about half of type 2 diabetes patients and roughly two-thirds of others quit GLP-1s within a year, citing side effects and cost.
Recap by typeshit. Post by Females on Instagram.
A Facebook share says Danish teams found certain bacterial strains may change how the gut tells the brain it is full. The work so far is in animal models only.
Bikman calls the results remarkable, but he argues that bigger drops make it more important to know how much of the lost weight is fat and how much is muscle.
Bikman points out that weight usually returns once the drug is stopped, which makes the question of lifelong use a real one.
Avi Roy flags a preprint that pooled 10,052 people from five semaglutide trials and used a blood test to estimate heart age. It has not yet been peer reviewed.
The list covers orforglipron's US approval, ecnoglutide in China and Hanmi's efpeglenatide in Korea, with each asset's stage and best disclosed weight change.
A short gym clip poking fun at Hollywood's Ozempic habit by suggesting lifting weights and eating ground beef instead. Light on detail.
Loading…